Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor VII and haemostasis.

B Osterud1

  • 1Institute of Medical Biology, University of Tromsø, Norway.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The key roles of complement and tissue factor in Escherichia coli-induced coagulation in human whole blood.

Clinical and experimental immunology·2015
Same author

Procoagulant and proinflammatory effects of red blood cells on lipopolysaccharide-stimulated monocytes.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Alterations in markers of coagulation and fibrinolysis in patients with Paroxysmal Nocturnal Hemoglobinuria before and during treatment with eculizumab.

Thrombosis research·2015
Same author

Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin.

Spinal cord·2015
Same author

The partial thromboplastin time: reply.

Journal of thrombosis and haemostasis : JTH·2014
Same author

C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.

Clinical and experimental immunology·2013
Same journal

Pampiniform venous plexus thrombosis in a 37 years-old male patient with severe thrombocytosis: a multifactorial aetiology.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

PROS1 Cys475Tyr mutation associated with a type III protein S deficiency pattern.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Dynamic microclot profiling: thromboelastography advances precision management in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Genetic characterization of Glanzmann thrombasthenia: insights from novel igta2b mutations in a Tunisian patient cohort.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Uterine fibroids as an underrecognized risk factor for venous thromboembolism: a narrative review.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

SEER sonorheometry enhances fibrinolysis detection during liver transplantation with heparin.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
See all related articles

Factor VII activation to factor VIIa is essential for initiating blood coagulation. This process, involving thromboplastin and factor Xa, may explain why factor VII deficiency is linked to thrombosis.

Area of Science:

  • Hematology
  • Biochemistry
  • Thrombosis Research

Background:

  • Factor VII's role in hemostasis and thrombosis is under renewed investigation.
  • Current understanding suggests factor VII activation to factor VIIa is mandatory for initiating blood coagulation.

Purpose of the Study:

  • To propose a hypothetical model for blood coagulation initiation and activation steps.
  • To explore the link between factor VII deficiency and thrombotic episodes.
  • To discuss the therapeutic applications of recombinant factor VIIa.

Main Methods:

  • Literature review and synthesis of existing studies.
  • Development of a hypothetical model for coagulation initiation.
  • Discussion of clinical observations and therapeutic strategies.

Related Experiment Videos

Main Results:

  • A model where circulating activators convert inactive thromboplastin-factor VII complexes to active factor VIIa is proposed.
  • Factor Xa is identified as a key accelerator of factor VII activation.
  • The model aligns with clinical findings of thrombotic episodes in moderate factor VII deficiency.

Conclusions:

  • Factor VII activation is a critical regulatory step in blood coagulation.
  • The proposed model provides a framework for understanding coagulation initiation.
  • Further research into factor VII's role in hemostasis and thrombosis is warranted, including its therapeutic potential.